Paradiem LLC grew its stake in Cabot Co. (NYSE:CBT - Free Report) by 17.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 132,275 shares of the specialty chemicals company's stock after purchasing an additional 19,903 shares during the quarter. Cabot makes up 3.2% of Paradiem LLC's holdings, making the stock its 11th biggest position. Paradiem LLC owned about 0.24% of Cabot worth $12,078,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also recently modified their holdings of CBT. Wolff Wiese Magana LLC purchased a new position in Cabot in the third quarter worth approximately $25,000. UMB Bank n.a. grew its position in shares of Cabot by 53.9% in the 3rd quarter. UMB Bank n.a. now owns 371 shares of the specialty chemicals company's stock valued at $41,000 after buying an additional 130 shares during the last quarter. Farther Finance Advisors LLC lifted its stake in Cabot by 197.9% in the third quarter. Farther Finance Advisors LLC now owns 417 shares of the specialty chemicals company's stock valued at $47,000 after buying an additional 277 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in Cabot by 33.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 475 shares of the specialty chemicals company's stock worth $48,000 after purchasing an additional 119 shares during the period. Finally, CWM LLC lifted its position in Cabot by 35.6% during the 3rd quarter. CWM LLC now owns 564 shares of the specialty chemicals company's stock worth $63,000 after acquiring an additional 148 shares during the period. Institutional investors and hedge funds own 93.18% of the company's stock.
Analyst Upgrades and Downgrades
A number of research analysts have recently issued reports on CBT shares. JPMorgan Chase & Co. lowered shares of Cabot from a "neutral" rating to an "underweight" rating and set a $105.00 price target on the stock. in a research note on Monday, November 11th. Mizuho dropped their target price on Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Cabot currently has a consensus rating of "Hold" and a consensus price target of $102.00.
Check Out Our Latest Analysis on CBT
Insider Activity at Cabot
In other Cabot news, CAO Lisa M. Dumont sold 865 shares of the firm's stock in a transaction dated Wednesday, November 13th. The shares were sold at an average price of $111.74, for a total transaction of $96,655.10. Following the sale, the chief accounting officer now directly owns 9,742 shares of the company's stock, valued at $1,088,571.08. This trade represents a 8.15 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Hobart Kalkstein sold 34,759 shares of Cabot stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $115.23, for a total transaction of $4,005,279.57. Following the sale, the executive vice president now owns 50,627 shares of the company's stock, valued at approximately $5,833,749.21. This trade represents a 40.71 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,190 shares of company stock valued at $5,751,534. Insiders own 3.07% of the company's stock.
Cabot Price Performance
Shares of CBT traded down $2.28 during trading hours on Thursday, reaching $89.30. The company had a trading volume of 503,990 shares, compared to its average volume of 322,042. The company has a current ratio of 2.08, a quick ratio of 1.36 and a debt-to-equity ratio of 0.68. Cabot Co. has a 12-month low of $70.63 and a 12-month high of $117.46. The firm has a 50 day simple moving average of $98.37 and a 200-day simple moving average of $102.29. The company has a market capitalization of $4.86 billion, a price-to-earnings ratio of 13.25, a PEG ratio of 0.79 and a beta of 1.21.
Cabot (NYSE:CBT - Get Free Report) last issued its earnings results on Monday, November 4th. The specialty chemicals company reported $1.80 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.81 by ($0.01). The company had revenue of $1 billion during the quarter, compared to analysts' expectations of $1.01 billion. Cabot had a net margin of 9.51% and a return on equity of 26.60%. The company's quarterly revenue was up 3.7% on a year-over-year basis. During the same period last year, the business posted $1.65 earnings per share. Research analysts expect that Cabot Co. will post 7.67 earnings per share for the current year.
Cabot Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Friday, February 28th will be paid a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 1.93%. The ex-dividend date of this dividend is Friday, February 28th. Cabot's dividend payout ratio (DPR) is presently 25.52%.
Cabot declared that its Board of Directors has approved a share buyback plan on Tuesday, December 3rd that authorizes the company to repurchase 10,000,000 shares. This repurchase authorization authorizes the specialty chemicals company to purchase shares of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's leadership believes its stock is undervalued.
Cabot Profile
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Recommended Stories
Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.